Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amodiaquine (camoquin) (3 trials)
coartem (4 trials)
dihydroartemisinin (1 trial)
lumefantrine (Coartem) (4 trials)
piperaquine (1 trial)
pyrimethamine (daraprim) (4 trials)
quinine (qualaquin) (2 trials)
sulfadoxine (4 trials)
yellow fever vaccine 17d strain (1 trial)
acetylsalicylic acid (aspirin) (1 trial)
dihydroqinghaosu (1 trial)
gentamicin (garamycin) (1 trial)
ivermectin (stromectol) (2 trials)
piperaquinoline (1 trial)
streptomycin (kabikinase) (1 trial)
ciprofloxacin (cipro) (1 trial)
doxylamine (1 trial)
phenytoin (mesantoin) (1 trial)
pyridoxine (1 trial)
valproic acid (depakene) (1 trial)
acetaminophen (tylenol) (1 trial)
albendazole (Albenza) (2 trials)
COVID-19 convalescent plasma (1 trial)
praziquantel (biltricide) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
Blister (Phase 3)
Fever (Phase 4)
Malaria (Phase 4)
Malaria, Cerebral (Phase 3)
Malaria, Falciparum (Phase 3)
Nodding Syndrome (Phase 2)
Plague (Phase 3)
Syndrome (Phase 2)
Yellow Fever (Phase 4)
Trials (18 total)
Trial APIs (25 total)